News
Apogee Therapeutics Advances in Clinical Trials for Promising Treatments in Inflammatory Diseases, and Reported Net Loss of $(32.1)M, Held $816.2M in Cash
13 May 24
Earnings, News
B of A Securities Initiates Coverage On Apogee Therapeutics with Buy Rating, Announces Price Target of $80
10 May 24
News, Price Target, Initiation, Analyst Ratings
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
14 Mar 24
News, Short Ideas, Pre-Market Outlook, Markets, Trading Ideas
Reported Earlier, Apogee Therapeutics Prices Upsized $420M Underwritten Public Offering Of 6,774,193 Common Shares At $62/Share
8 Mar 24
News
Jefferies Maintains Buy on Apogee Therapeutics, Raises Price Target to $75
6 Mar 24
News, Price Target, Analyst Ratings
Apogee Therapeutics Announces Commencement Of $350M Proposed Underwritten Public Offering
5 Mar 24
News, Offerings
Crude Oil Down 1%; Dave Shares Jump After Q4 Results
5 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Stifel Maintains Buy on Apogee Therapeutics, Raises Price Target to $95
5 Mar 24
News, Price Target, Analyst Ratings
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
5 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Guggenheim Maintains Buy on Apogee Therapeutics, Raises Price Target to $91
5 Mar 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's Intraday Session
5 Mar 24
Movers
Nasdaq Down 250 Points; ISM Services PMI Falls In February
5 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Is Atopic Dermatitis-Focused Apogee Therapeutics Stock Trading Higher On Tuesday?
5 Mar 24
Biotech, Earnings, News, Guidance, Health Care, Movers, General
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
5 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Dow Dips Over 100 Points; Target Posts Upbeat Earnings
5 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Market-Moving News for March 5th
5 Mar 24
Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
5 Mar 24
Movers
Apogee Announces Interim Results from Phase 1 Healthy Volunteer Trial for APG777, for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Schedule
5 Mar 24
News
Apogee To Host Conference Call And Webcast To Report Interim Results From Phase 1 Healthy Volunteer Trial For APG777 For Atopic Dermatitis And Other Inflammatory Diseases On March 5, 2024
4 Mar 24
Biotech, News, Events, General
Press releases
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
25 Mar 24
Press Releases
Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $483 Million
12 Mar 24
Press Releases
Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
7 Mar 24
Press Releases
Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
5 Mar 24
Earnings, Health Care, Press Releases
Apogee Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Schedule with Half-Life of Approximately 75 Days
5 Mar 24
Press Releases
Apogee to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases on March 5, 2024
4 Mar 24
News, Health Care, Press Releases